Amphastar Pharmaceuticals, Inc. (AMPH)

Last Closing Price: 19.74 (2026-06-05)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Amphastar Pharmaceuticals, Inc. (AMPH) had Net Income of $6.42M for the most recently reported fiscal quarter, ending 2026-03-31.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$171.17M
Net Income
$6.42M
$100.85M
$70.32M
$157.54M
$13.63M
$-3.58M
$10.05M
$10.05M
$6.42M
$6.42M
$6.42M
$6.42M
$13.63M
$28.74M
45.32M
46.46M
$0.14
$0.14
Balance Sheet Financials
$633.68M
$307.23M
$1.01B
$1.65B
$164.48M
$609.80M
$710.29M
$874.77M
$773.39M
$213.77M
$773.39M
44.64M
Cash Flow Statement Financials
$47.84M
$-16.73M
$-30.21M
$170.41M
$171.17M
$0.76M
$9.27M
--
--
Fundamental Metrics & Ratios
3.85
--
--
0.44
0.79
41.08%
7.96%
7.96%
--
5.87%
3.75%
$38.33M
--
--
--
0.10
0.59
1.09
82.79
0.83%
3.00%
0.39%
0.46%
$17.33
$0.83
$1.03